These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 22221894)
1. Mutant Hras(G12V) and Kras(G12D) have overlapping, but non-identical effects on hepatocyte growth and transformation frequency in transgenic mice. Figueiredo ML; Stein TJ; Jochem A; Sandgren EP Liver Int; 2012 Apr; 32(4):582-91. PubMed ID: 22221894 [TBL] [Abstract][Full Text] [Related]
2. Minimal cooperation between mutant Hras and c-myc or TGFα in the regulation of mouse hepatocyte growth or transformation in vivo. Stein TJ; Bowden M; Sandgren EP Liver Int; 2011 Oct; 31(9):1298-305. PubMed ID: 22093452 [TBL] [Abstract][Full Text] [Related]
3. Triiodothyronine (T3) suppresses hepatic tumorigenesis and development by inhibiting the phosphorylation of ERK. Dong L; Zhang N; Chen J; Dong P; Mao N; Li H; Wang A Mol Carcinog; 2024 Oct; 63(10):1988-2000. PubMed ID: 39031486 [TBL] [Abstract][Full Text] [Related]
4. Peroxiredoxin II promotes hepatic tumorigenesis through cooperation with Ras/Forkhead box M1 signaling pathway. Park YH; Kim SU; Kwon TH; Kim JM; Song IS; Shin HJ; Lee BK; Bang DH; Lee SJ; Lee DS; Chang KT; Kim BY; Yu DY Oncogene; 2016 Jul; 35(27):3503-13. PubMed ID: 26500057 [TBL] [Abstract][Full Text] [Related]
5. Synergistic function of Kras mutation and HBx in initiation and progression of hepatocellular carcinoma in mice. Ye H; Zhang C; Wang BJ; Tan XH; Zhang WP; Teng Y; Yang X Oncogene; 2014 Oct; 33(43):5133-8. PubMed ID: 24213574 [TBL] [Abstract][Full Text] [Related]
6. Effect of mutant β-catenin on liver growth homeostasis and hepatocarcinogenesis in transgenic mice. Stein TJ; Jochem A; Holmes KE; Sandgren EP Liver Int; 2011 Mar; 31(3):303-12. PubMed ID: 21281430 [TBL] [Abstract][Full Text] [Related]
8. Generation of combined hepatocellular-cholangiocarcinoma through transdifferentiation and dedifferentiation in p53-knockout mice. Liu Y; Xin B; Yamamoto M; Goto M; Ooshio T; Kamikokura Y; Tanaka H; Meng L; Okada Y; Mizukami Y; Nishikawa Y Cancer Sci; 2021 Aug; 112(8):3111-3124. PubMed ID: 34051011 [TBL] [Abstract][Full Text] [Related]
9. Higher metastatic efficiency of KRas G12V than KRas G13D in a colorectal cancer model. Alamo P; Gallardo A; Di Nicolantonio F; Pavón MA; Casanova I; Trias M; Mangues MA; Lopez-Pousa A; Villaverde A; Vázquez E; Bardelli A; Céspedes MV; Mangues R FASEB J; 2015 Feb; 29(2):464-76. PubMed ID: 25359494 [TBL] [Abstract][Full Text] [Related]
10. Differences in gynecologic tumor development in Amhr2-Cre mice with KRAS Kun EHS; Tsang YTM; Lin S; Pan S; Medapalli T; Malpica A; Richards JS; Gershenson DM; Wong KK Sci Rep; 2020 Nov; 10(1):20678. PubMed ID: 33244099 [TBL] [Abstract][Full Text] [Related]
11. Crosstalk of Ras and Rho: activation of RhoA abates Kras-induced liver tumorigenesis in transgenic zebrafish models. Chew TW; Liu XJ; Liu L; Spitsbergen JM; Gong Z; Low BC Oncogene; 2014 May; 33(21):2717-27. PubMed ID: 23812423 [TBL] [Abstract][Full Text] [Related]
12. Critical role of Myc activation in mouse hepatocarcinogenesis induced by the activation of AKT and RAS pathways. Xin B; Yamamoto M; Fujii K; Ooshio T; Chen X; Okada Y; Watanabe K; Miyokawa N; Furukawa H; Nishikawa Y Oncogene; 2017 Sep; 36(36):5087-5097. PubMed ID: 28481866 [TBL] [Abstract][Full Text] [Related]
13. Gene expression deregulation by KRAS G12D and G12V in a BRAF V600E context. Monticone M; Biollo E; Maffei M; Donadini A; Romeo F; Storlazzi CT; Giaretti W; Castagnola P Mol Cancer; 2008 Dec; 7():92. PubMed ID: 19087308 [TBL] [Abstract][Full Text] [Related]
14. Myocardial KRAS(G12D) expression does not cause cardiomyopathy in mice. Dalin MG; Zou Z; Scharin-Täng M; Safari R; Karlsson C; Bergo MO Cardiovasc Res; 2014 Feb; 101(2):229-35. PubMed ID: 24259500 [TBL] [Abstract][Full Text] [Related]
15. Transcriptomic analyses of oncogenic hepatocytes reveal common and different molecular pathways of hepatocarcinogenesis in different developmental stages and genders in kras Huo X; Li H; Li Z; Yan C; Mathavan S; Liu J; Gong Z Biochem Biophys Res Commun; 2019 Mar; 510(4):558-564. PubMed ID: 30739784 [TBL] [Abstract][Full Text] [Related]
17. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice. Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677 [TBL] [Abstract][Full Text] [Related]
18. Expression profiling of the influence of RAS mutants on the TGFB1-induced phenotype of the pancreatic cancer cell line PANC-1. Fensterer H; Giehl K; Buchholz M; Ellenrieder V; Buck A; Kestler HA; Adler G; Gierschik P; Gress TM Genes Chromosomes Cancer; 2004 Mar; 39(3):224-35. PubMed ID: 14732924 [TBL] [Abstract][Full Text] [Related]
19. Hill MA; Alexander WB; Guo B; Kato Y; Patra K; O'Dell MR; McCall MN; Whitney-Miller CL; Bardeesy N; Hezel AF Cancer Res; 2018 Aug; 78(16):4445-4451. PubMed ID: 29871934 [TBL] [Abstract][Full Text] [Related]
20. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail. Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]